Skip to main content
Download PDF

Detection of vector-borne pathogens in owned dogs with cranial cruciate ligament rupture living in the Mediterranean area

Parasites & Vectors volume 15, Article number: 105 (2022) Cite this article

Abstract

Background

Cranial cruciate ligament rupture (CCLR) results from a multifactorial degenerative process that leads to rupture of the ligament. Vector-borne pathogens (VBP) in dogs can induce joint disease but their role in CCLR has not been previously investigated. The aim of the present work is to evaluate the prevalence of VBP in dogs with CCLR.

Methods

This was a prospective study that included 46 dogs presented for CCLR surgical treatment and 16 control dogs euthanized for diseases unrelated to the joints. Specimens collected included blood, synovial fluid, and synovial membrane biopsy. Pathogen testing consisted of serology for Leishmania infantum (quantitative ELISA), Ehrlichia canis/ewingii, Borrelia burgdorferi, Anaplasma phagocytophilum/platys, and Dirofilaria immitis (4DX IDEXX test), and PCR for L. infantum, Ehrlichia/Anaplasma spp., Bartonella spp., piroplasms (Babesia spp. and Theileria spp.), and filariae (D. immitis, Dirofilaria repens, Acanthocheilonema dracunculoides, Acanthocheilonema reconditum, and Cercopithifilaria spp.) on both EDTA-whole blood (EB) and synovial fluid (SF) samples. SF cytology and histopathological evaluation of synovial membrane were also performed.

Results

The prevalence of VBP was 19.6% in the CCLR group and 18.8% in the control group, with no statistical difference among them. The presence of synovitis was not more frequent in CCLR dogs (45.6%) than in control dogs (43.7%). Lymphoplasmacytic infiltration was the most common inflammatory pattern detected in the joints of both groups of dogs.

Conclusions

This study failed to demonstrate a role of canine VBP in CCLR or the presence or different pattern of joint inflammation in pathogen-positive dogs.

Graphical Abstract

Background

Cranial cruciate ligament rupture (CCLR) is a common cause of pelvic limb lameness in dogs that results most often from a degenerative process that leads to rupture of the ligament. Several risk factors have been described, such as age, breed, sex, neutering status, and weight [1, 2]. However, CCLR is likely to have a multifactorial origin involving genetics, anatomic conformation, and chronic joint inflammation, eventually leading to rupture of the ligament and osteoarthritis [3, 4]. It has been suggested that immunopathological mechanisms may be involved in the development of degenerative CCL lesions [5] and, furthermore, lymphoplasmacytic synovitis is a common finding in dogs with CCLR [6]. Therefore, two hypotheses have been proposed regarding the role of chronic synovitis in the development of cruciate ligament fiber damage and, consequently, CCLR. The first is that synovitis is an early and primary event inducing progressive ligament fiber disruption [7]. The second is that several intrinsic factors may induce minor fiber ruptures with subsequent induction of chronic synovitis that itself contributes to the degenerative changes in the ligament, culminating in CCLR [7].

Previous publications reported an increased bacterial load in synovial membrane biopsies of inflamed stifles of dogs with CCLR in comparison with healthy stifles, suggesting that environmental bacteria can induce persistent chronic synovitis [8, 9]. Other kinds of pathogens such as vector-borne pathogens (VBP) can induce acute and chronic joint disease in dogs, but their role in CCLR has not been thoroughly investigated [10,11,12,13,14]. A recent study performed in Brazil reported that 91.3% of 46 dogs with leishmaniasis presented joint abnormalities observed on physical examination, radiography, and/or computed tomography, but CCLR was not included in the list of joint anomalies described [14]. Other VBP such as Ehrlichia canis, Anaplasma phagocytophilum, Rickettsia rickettsii, Borrelia burgdorferi, Babesia canis, Bartonella vinsonii subsp. berkhoffii, and filariae have been also linked to joint disease, such as polyarthritis, in dogs [4, 10, 15,16,17,18,19,20,21,22,23,24].

This study aims to detect several VBP in owned dogs with CCLR, to determine if there is an association between the presence of VBP and CCLR, and to identify the presence of a specific inflammatory pattern in the synovial membrane of dogs with CCLR and VBP.

Methods

Patient selection

This prospective cohort study was conducted from June 2016 until October 2019 in a referral veterinary hospital located in the Mediterranean basin. Forty-six dogs presented for CCLR surgical treatment and 16 control dogs that were humanely euthanized for suffering from different serious diseases that did not affect the joints, were prospectively included during that period.

Complete information obtained for the 46 dogs included age, sex, breed, body weight, general and orthopedic examination, location of CCLR (unilateral or bilateral), and pre-anesthetic urine and blood analysis. Furthermore, clinical reports for all dogs included in this study were reviewed to look for diagnosis of vector-borne disease, before surgery or euthanasia, or at any time after surgery until the end of the study (follow-up ranged from 1.5 to 4.5 years). Owner consent was received for all dogs prior to their enrolment in the study. This study was carried out in accordance with ethical guidelines of the International Council for Laboratory Animal Science.

Sampling

Blood was collected by cephalic or jugular venipuncture from all dogs. Synovial fluid (SF) samples were collected immediately prior to the surgery or euthanasia, following anesthetic induction and aseptic preparation of the limb. Smears were made immediately after collection, obtained following cytocentrifugation, and 0.5 ml of synovial fluid was placed in a tube containing calcium ethylenediaminetetraacetic acid (EDTA).

Incisional synovial membrane biopsy specimens were obtained from the affected joint of dogs with CCLR or from a random stifle joint of control dogs following caudomedial parapatellar arthrotomy (1 cm sample from each dog). Synovial biopsy samples were fixed in neutral buffered 10% formalin and routinely processed for histologic examination.

Serum samples were archived and used for the detection and quantification of organism-specific serology. Both EDTA-blood and EDTA-SF samples from all dogs were stored frozen for posterior polymerase chain reaction (PCR) analysis. All serology and PCR analysis were performed at the same time at the end of the study.

Serology

A quantitative enzyme-linked immunosorbent assay (LEISCAN® enzyme-linked immunosorbent assay [ELISA]) was performed for Leishmania infantum antibody detection (IDEXX Barcelona, Spain), which has a cut-off of 0.55, with values > 0.55 considered positive. A commercial qualitative assay kit (SNAP 4DX Plus IDEXX, Hoofddorp, Netherlands) was employed for the detection of E. canis/ewingii, B. burgdorferi, and A. phagocytophilum/platys antibodies, and D. immitis antigen.

DNA extraction and PCR amplification

DNA was extracted from 400 µl of both blood and SF samples as previously described [25]. Collected samples, previously defined as specific pathogen-free by PCR, were used as an extraction negative control in each extraction batch. Samples were tested in an operator blind manner, and piroplasms (Babesia spp. and Theileria spp.), Bartonella spp., Ehrlichia/Anaplasma spp., and filariae [D. immitis, Dirofilaria repens, Acanthocheilonema dracunculoides, Acanthocheilonema reconditum, and Cercopithifilaria spp.] were targeted using genus-specific PCR assays [26]. Briefly, real-time PCR was carried out in a total volume of 20 μl containing SYBR® Select Master Mix (Thermo Fisher Scientific), specific primer, and 4 μl of 1/5 diluted DNA. The thermal cycling profile was 50 °C for 2 min and 95 °C for 15 s and 60 °C for 1 min, and a dissociation curve added at the end of the run. Water was used as a PCR negative control and commercial DNAs as positive PCR control. Quantitative L. infantum PCR was performed as described by Francino et al. [25]. Leishmania infantum DNA load was classified as very low, low, medium, high, or very high load as reported by MartĂ­nez et al. [27]. The eukaryotic 18S ribosomal ribonucleic acid (rRNA) (Thermo Fisher Scientific) was used as an endogenous control to ensure proper DNA extraction.

Sequencing

In all cases in which SF or blood samples were PCR-positive, direct DNA sequencing was performed to characterize pathogens at the species level. Sequencing was carried out using the BigDye® Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific) following the manufacturer instructions and with the same primer used in the PCR and sequences compared with the GenBank database (https://blast.ncbi.nlm.nih.gov/Blast.cgi).

Cytologic and histologic examination

Synovial fluid smears, obtained following cytocentrifugation, were stained with a rapid modified Romanowsky stain (QUICK PANOPTIC, QuĂ­mica ClĂ­nica Aplicada, Amposta, Spain), and light microscopy examination was performed only to detect the presence of pathogens.

Hematoxylin and eosin-stained biopsies of synovial membranes were evaluated by light microscopy. Samples were evaluated for the presence and pattern of inflammatory cells and characterized as lymphoplasmacytic, granulomatous, neutrophilic, or mixed. Dogs were considered to have synovitis if more than one inflammatory cell/high-power field (hpf) was identified.

Statistical analysis

Statistical analysis was performed using commercially available statistical software (IBM SPSS Statistics v.19). Values for the prevalence of VBP (positivity to any of them) and for the presence of inflammation in joint capsule biopsy were established. Contingency table analysis was performed. Chi-square test and Fisher’s exact test were used to compare proportions of positivity, and statistical significance was set at P-value ≤ 0.05.

Results

This study included 62 dogs, 46 with CCLR and 16 controls. Among CCLR dogs there were 25 females (17 intact and eight spayed) and 21 males (15 intact and six spayed), that ranged from 6 months to 11 years in age. There were 16 different breeds, with the most common being mongrel dogs (n = 18). In the control group there were eight females (four intact and four spayed) and eight males (six intact and two spayed) that ranged from 4 to 17 years in age, and 10 different breeds (Additional file 1: Table S1). Reasons for euthanasia included neoplasia (five), chronic renal failure (two), gastric dilatation-volvulus (one), pituitary hyperadrenocorticism (one), discal hernia (two), urethral obstruction (one), cardiac failure (two), refractory epilepsy (one), and acute liver failure (one). There was no previous clinical history, clinical signs, or clinicopathological abnormalities consistent with VBP infection in any of the dogs included in this study.

The prevalence of VBP in the CCLR group was 19.6% (9/46). Leishmania infantum was detected in six dogs, with three seropositive, one SF-PCR-positive, and two both seropositive and SF-PCR-positive. Ehrlichia spp. were found in three dogs, with two seropositive and one seropositive and blood-PCR-positive (E. canis). One of those dogs was co-infected with L. infantum (SF-PCR-positive) and Ehrlichia spp. (seropositive). Finally, Theileria equi DNA was detected in the SF sample of one dog (Additional file 2: Table S2).

Among the control group, the prevalence of canine VBP was 18.8% (3/16). All three dogs were positive for L. infantum, with one seropositive, one blood-PCR-positive, and one seropositive and both blood- and SF-PCR-positive (Additional file 2: Table S2).

No VBP were detected by light microscopy in any SF-smear of any dog included in this study, and the total prevalence of VBP was not statistically different between dogs with CCLR and control dogs [odds ratio (OR) = 0.949, 95% confidence interval (CI) 0.22–4.05, P = 0.629].

Unilateral CCLR was detected in 29 dogs (five of them with VBP), while CCLR was bilateral in 17 dogs (four of them with VBP), meaning that the presence of bilateral CCLR was not statistically more frequent among dogs with VBP (OR = 0.677, 95% CI 0.15–2.97, P = 0.439).

Histopathology of biopsies of synovial membranes yielded synovitis in 45.6% (21/46) of dogs with CCLR, with various inflammatory patterns including lymphoplasmacytic (17), neutrophilic (one), granulomatous (one), and mixed lymphoplasmacytic and granulomatous (two); and in 43.7% (7/16) of control dogs, all of them with lymphoplasmacytic infiltration. Presence of synovitis was not statistically more frequent in dogs with CCLR compared with control dogs (χ2 = 0.017, df = 1, P = 0.895) or in dogs with or without VBP (χ2 = 0.141, df = 1, P = 0.708). Furthermore, a different or specific inflammatory pattern was not detected among dogs with VBP, independently of whether they had CCLR or were control dogs (Additional file 2: Table S2).

When the outcome of VBP-positive dogs with CCLR was reviewed, two of three dogs with L. infantum SF-PCR-positive, but without previous clinical history or diagnosis of Leishmania infection, developed clinical signs consistent with patent leishmaniasis between 9 to 12 months after CCLR surgery (Additional file 2: Table S2).

Discussion

This study failed to demonstrate a role of VBP in CCLR or the presence of a specific pattern of joint inflammation in VBP-positive dogs, even though several canine vector-borne diseases have been associated with joint damage [4, 10, 14, 16,17,18,19,20,21,22, 24], and some of them, especially leishmaniasis, are considered endemic in the area where the present study was performed [28]. Larger case–control studies would likely be needed to clarify the role of various vector-borne organisms as a cause or cofactor in the development of CCLR.

In canine leishmaniasis, the frequency of orthopedic problems had been reported to range from 44.8% to as high as 91.3%, when both orthopedic examination and imaging (radiology and/or computed tomography) were combined to look for joint abnormalities [14, 29]. Some anomalies found in the orthopedic examination include joint stiffness, lameness, soft tissue swelling, joint pain or crepitation, and functional disability. Notably, dogs with CCLR can have one or more of these described orthopedic abnormalities, but in previous studies there was no specific information about the prevalence of CCLR in dogs suffering from leishmaniasis. Theoretically, lameness in leishmaniasis could be produced by polyarthritis, with additional bone or muscle involvement, usually secondary to inflammation associated with the deposition of immune complexes within the joint because of a type III hypersensitivity reaction [4, 12, 30]. However, primary joint infection could also occur, and parasites have been identified within macrophages by cytologic evaluation of the synovial fluid and by histologic assessment of the synovial membranes [31, 32]. Thus, infected dogs could present with monoarthritis, oligoarthritis, or polyarthritis [18], and some reports indicate that stifle joint could be affected in close to 80% of cases [14]. In this study, L. infantum was the most frequent VBP detected in dogs with CCLR, although its prevalence was not significantly different from that in control dogs, suggesting no role of Leishmania infection in the pathogenesis of CCLR. A potential explanation for its detection in both groups of dogs could be the high prevalence of subclinical infection present in an endemic area of leishmaniasis [28, 33].

An association of polyarthritis with ehrlichiosis has been reported previously; however, there was no firm evidence to support it, and other possible co-infections were not ruled out, meaning that the relationship was controversial [10, 15,16,17]. In the present study, three dogs with CCLR were found to have Ehrlichia antibodies or DNA. However, in the two only seropositive dogs, infection could not be confirmed, and perhaps it could simply reflect exposure or past infection. The third dog, seropositive and E. canis PCR-positive, never developed any other clinical sign or laboratory abnormality consistent with patent or subclinical ehrlichiosis, either before or after CCLR surgery. This could imply that this dog perhaps was in an acute stage of the disease and could have recovered alone, or that it was in a subclinical stage. Either of these two scenarios probably rules out a relationship between CCLR and Ehrlichia infection.

Theileria equi is one of the equine piroplasms which is enzootic in Spain, with almost half of the horses having antibodies or circulating parasitemia [34]. This parasite has occasionally been detected in dogs, although its epidemiological and clinical significance remains unknown [35]. All the above, together with the fact that the dog in this study with T. equi in SF did not demonstrate any other clinicopathological abnormalities throughout the study period, could suggest that this pathogen was opportunistic without clinical significance on CCLR.

Although Bartonella, A. phagocytophilum, B. burgdorferi, filariae, or other piroplasms such as Babesia have been associated with acute or chronic canine polyarthritis [10, 13, 17, 19,20,21,22, 36], no dog in this study was positive for any of them. Those findings could be in concordance with the local geographic prevalence of those VBP reported in previous studies in the area evaluated in this study [16, 27, 34, 37]. However, it is worth noting that the limitations regarding the sensitivity of the techniques used and the limitations associated with the specimens collected for testing could also have contributed to failure to detect these organisms.

Lymphoplasmacytic arthritis was the most frequent histopathological finding in this study, in dogs both with and without CCLR. This agrees with previous publications where lymphoplasmacytic synovitis has been commonly described in dogs with CCLR [6], but it has also been detected in post-mortem samples from dogs without CCLR [7]. On the other hand, reactive immune-mediated arthritis due to deposition of developed immune complexes secondary to VBP infection is predominately neutrophilic [4, 11, 12, 18, 29]. This fact reinforces the idea that VBP did not play any role in the pathogenesis of CCLR, together with the fact that neither inflammatory pattern nor frequency of synovitis was statistically different between dogs with or without CCLR or between dogs with or without VBP in this study. However, although not statistically significant, three dogs with CCLR in this study showed granulomatous synovitis, a kind of inflammation also reported in several tissues in dogs with leishmaniasis [33, 38], but only one of them was positive for leishmaniasis. Although granulomatous inflammation is usually associated with the presence of Leishmania within the tissue [12, 13], amastigotes could not be detected in this seropositive and Leishmania PCR-positive dog with granulomatous synovitis. The cause of granulomatous inflammation in the other two dogs remains undetermined. Therefore, the current study could not definitely rule out a potential role of this VBP in the pathogenesis of synovitis and perhaps of CCLR in some of these dogs.

This study has some limitations. The low number of dogs included, due to the difficulty in recruiting cases due to the strict inclusion criteria and the fact that it was a prospective study with a control group, means that the statistical results must be taken with caution. Moreover, only dogs that received CCLR surgical treatment were included, excluding dogs initially diagnosed with VBP and CCLR that ultimately did not undergo surgery. An additional limitation was the wide variety of diseases that led to the euthanasia of control dogs and the fact that articular surfaces were not evaluated, especially knowing that the control population had a higher mean age. However, previous medical histories were extensively evaluated to exclude previous infections with VBP or diseases that could affect the joints. Furthermore, control dogs were also included during the same period and area as CCLR dogs, thus limiting the bias in the probabilities of VBP detection. Finally, the last limitation was the identification of the presence of VBP. In this study we used serology, microscopy in SF cytology, and synovial membrane biopsy, as well as PCR in blood and SF, seeking to maximize the chances of VBP detection. However, the positive serologies were not conclusive of causality of the abnormalities found in the joint. Moreover, it was not possible to perform serology for all the pathogens sought for, nor could immunohistochemistry and/or PCR on the biopsy be performed to increase the probability of detection of selected VBP.

Conclusions

This study failed to demonstrate a role of several VBP in the pathogenesis of CCLR in dogs, or the presence or a different pattern of joint inflammation in pathogen-positive dogs. However, to overcome the limitations of this study, additional studies may be warranted to clarify the potential relationship between VBP and CCLR in dogs.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CCLR:

Cranial cruciate ligament rupture

VBP:

Vector-borne pathogens

D :

Dirofilaria

A :

Acanthocheilonema

EB:

EDTA-blood

SF:

Synovial fluid

E :

Ehrlichia

L :

Leishmania

References

  1. Brioschi V, Arthurs GI. Cranial cruciate ligament rupture in small dogs (<15 kg): a narrative literature review. J Small Anim Pract. 2021;62:1037–50.

    Article  CAS  Google Scholar 

  2. Gilbert S, Langenbach A, Marcellin-Little DJ, Pease AP, Ru H. Stifle joint osteoarthritis at the time of diagnosis of cranial cruciate ligament injury is higher in Boxers and in dogs weighing more than 35 kilograms. Vet Radiol Ultrasound. 2019;60:280–8.

    Article  Google Scholar 

  3. Comerford EJ, Smith K, Hayashi K. Update on the aetiopathogenesis of canine cranial cruciate ligament disease. Vet Comp Orthop Traumatol. 2011;24:91–8.

    Article  CAS  Google Scholar 

  4. Bennett D. Immune-mediated and infective arthritis. In: Ettinger SJ, Feldman EC, editors. Textb Vet Intern Med Dis Dog Cat. 7th ed. Missouri: Saunders; 2010. p. 743–9.

    Google Scholar 

  5. Doom M, de Bruin T, de Rooster H, van Bree H, Cox E. Immunopathological mechanisms in dogs with rupture of the cranial cruciate ligament. Vet Immunol Immunopathol. 2008;125:143–61.

    Article  CAS  Google Scholar 

  6. Erne JB, Goring RL, Kennedy FA, Schoenborn WC. Prevalence of lymphoplasmacytic synovitis in dogs with naturally occurring cranial cruciate ligament rupture. J Am Vet Med Assoc. 2009;235:386–90.

    Article  Google Scholar 

  7. Döring AK, Junginger J, Hewicker-Trautwein M. Cruciate ligament degeneration and stifle joint synovitis in 56 dogs with intact cranial cruciate ligaments: correlation of histological findings and numbers and phenotypes of inflammatory cells with age, body weight and breed. Vet Immunol Immunopathol. 2018;196:5–13.

    Article  Google Scholar 

  8. Muir P, Oldenhoff WE, Hudson AP, Manley PA, Schaefer SL, Markel MD, et al. Detection of DNA from a range of bacterial species in the knee joints of dogs with inflammatory knee arthritis and associated degenerative anterior cruciate ligament rupture. Microb Pathog. 2007;42:47–55.

    Article  CAS  Google Scholar 

  9. Schwartz Z, Zitzer NC, Racette MA, Manley PA, Schaefer SL, Markel MD, et al. Are bacterial load and synovitis related in dogs with inflammatory stifle arthritis? Vet Microbiol. 2011;148:308–16.

    Article  CAS  Google Scholar 

  10. Foley J, Drazenovich N, Leutenegger CM, Chomel BB. Association between polyarthritis and thrombocytopenia and increased prevalence of vectorborne pathogens in Californian dogs. Vet Rec. 2007;160:159–62.

    Article  CAS  Google Scholar 

  11. Stull JW, Evason M, Carr AP, Waldner C. Canine immune-mediated polyarthritis: clinical and laboratory findings in 83 cases in western Canada (1991–2001). Can Vet J. 2008;49:1195–203.

    PubMed  PubMed Central  Google Scholar 

  12. Day MJ. The immunopathology of canine vector-borne diseases. Parasit Vectors. 2011;4:48.

    Article  Google Scholar 

  13. Koutinas AF, Koutinas CK. Pathologic mechanisms underlying the clinical findings in canine leishmaniasis due to Leishmania infantum/chagasi. Vet Pathol. 2014;51:527–38.

    Article  CAS  Google Scholar 

  14. Silva ARS, Oliveira HS, Gomes AAD, Beserra HEO, Silva JP, Santos-Doni TR, et al. Joint involvement in canine visceral leishmaniasis: orthopedic physical examination, radiographic and computed tomographic findings. Vet Parasitol. 2021;299:109569.

    Article  CAS  Google Scholar 

  15. Bellah JR, Shull RM, Selcer EV. Ehrlichia canis-related polyarthritis in a dog. J Am Vet Med Assoc. 1986;189:922–3.

    CAS  PubMed  Google Scholar 

  16. Sainz A, Roura X, MirĂ³ G, Estrada-Peña A, Kohn B, Harrus S, et al. Guidelines for veterinary practitioners on canine ehrlichiosis and anaplasmosis in Europe. Parasit Vectors. 2015;8:75.

    Article  Google Scholar 

  17. Zandvliet MM, Teske E, Piek CJ. Ehrlichia and Babesia infections in dogs in The Netherlands. Tijdschr Diergeneeskd. 2004;129:740–5.

    CAS  PubMed  Google Scholar 

  18. Sbrana S, Marchetti V, Mancianti F, Guidi G, Bennett D. Retrospective study of 14 cases of canine arthritis secondary to Leishmania infection. J Small Anim Pract. 2014;55:309–13.

    Article  CAS  Google Scholar 

  19. Eberts MD, Diniz PPVP, Beall MJ, Stillman BA, Chandrashekar R, Breitschwerdt EB. Typical and atypical manifestations of Anaplasma phagocytophilum infection in dogs. J Am Anim Hosp Assoc. 2011;47:e86-94.

    Article  Google Scholar 

  20. Hodges S, Rishniw M. Intraarticular Dirofilaria immitis microfilariae in two dogs. Vet Parasitol. 2008;152:167–70.

    Article  Google Scholar 

  21. Gabrielli S, Giannelli A, Brianti E, Dantas-Torres F, Bufalini M, Fraulo M, et al. Chronic polyarthritis associated to Cercopithifilaria bainae infection in a dog. Vet Parasitol. 2014;205:401–4.

    Article  Google Scholar 

  22. Pérez C, Maggi RG, Diniz PPVP, Breitschwerdt EB. Molecular and serological diagnosis of Bartonella infection in 61 dogs from the United States. J Vet Intern Med. 2011;25:805–10.

    Article  Google Scholar 

  23. Rondeau MP, Walton RM, Bissett S, Drobatz KJ, Washabau RJ. Suppurative, nonseptic polyarthropathy in dogs. J Vet Int Med. 2005;19:654–62.

    Article  Google Scholar 

  24. Mylonakis ME, Soubasis N, Balakrishnan N, Theodorou K, Kasabalis D, Saridomichelakis M, et al. Molecular identification of Bartonella species in dogs with leishmaniosis (Leishmania infantum) with or without cytological evidence of arthritis. Vet Microbiol. 2014;174:272–5.

    Article  CAS  Google Scholar 

  25. Francino O, Altet L, Sanchez-Robert E, Rodriguez A, Solano-Gallego L, Alberola J, et al. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet Parasitol. 2006;137:214–21.

    Article  CAS  Google Scholar 

  26. Movilla R, Altet L, Serrano L, Tabar MD, Roura X. Molecular detection of vector-borne pathogens in blood and splenic samples from dogs with splenic disease. Parasit Vectors. 2017;10:131.

    Article  Google Scholar 

  27. MartĂ­nez V, Quilez J, Sanchez A, Roura X, Francino O, Altet L. Canine leishmaniasis: the key points for qPCR result interpretation. Parasit Vectors. 2011;4:57.

    Article  Google Scholar 

  28. MirĂ³ G, Montoya A, Roura X, GĂ¡lvez R, Sainz A. Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study. Parasit Vectors. 2013;6:117.

    Article  Google Scholar 

  29. Agut A, Corzo N, Murciano J, Laredo FG, Soler M. Clinical and radiographic study of bone and joint lesions in 26 dogs with leishmaniasis. Vet Rec. 2003;153:648–52.

    Article  CAS  Google Scholar 

  30. Slappendel RJ, Ferrer L. Leishmaniosisa. In: Greene CE, editor. Infect Dis Dog Cat. Philadelphia: Saunders; 1990. p. 450–7.

    Google Scholar 

  31. Lennox WJ, Smari ME, Littke PB. Canine leishmaniosis in Canada. Can Vet J. 1972;13:188–90.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Turrel JM, Pool R. Bone lesions in four dogs with visceral leishmaniasis. Vet Radiol. 1982;23:243–9.

    Article  Google Scholar 

  33. Solano D, MirĂ³ G, Koutinas A, Cardoso L, Pennisi MG, Ferrer L, et al. The LeishVet group. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit Vectors. 2011;4:86.

    Article  Google Scholar 

  34. Camino E, Buendia A, Dorrego A, Pozo P, de Juan L, Dominguez L, et al. Sero-molecular survey and risk factors of equine piroplasmosis in horses in Spain. Equine Vet J. 2021;53:771–9.

    Article  Google Scholar 

  35. Solano-Gallego L, Sainz A, Roura X, Estrada-Peña A, MirĂ³ G. A review of canine babesiosis: the European perspective. Parasit Vectors. 2016;9:336.

    Article  Google Scholar 

  36. Shaw SE, Day MJ, Lerga A, Birtles RJ, Kenny MJ. Anaplasma (Ehrlichia) phagocytophila: a cause of meningoencephalitis/polyarthritis in dogs? J Vet Intern Med. 2002;16:636.

    Google Scholar 

  37. Tabar MD, Francino O, Altet L, Sanchez A, Ferrer L, Roura X. PCR survey of vectorborne pathogens in dogs living in and around Barcelona, an area endemic for leishmaniasis. Vet Rec. 2009;164:112–6.

    Article  Google Scholar 

  38. Peña MT, Naranjo C, Klauss G, Fondevila D, Leiva M, Roura X, et al. Histopathological features of ocular leishmaniosis in the dog. J Comp Pathol. 2008;138:32–9.

    Article  Google Scholar 

Download references

Acknowledgements

The paper has been sponsored by Elanco Animal Health in the framework of the 16th CVBD® World Forum Symposium.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Hospital Veterinario San Vicente Vetsum, Calle del Veterinario Manuel Isidro RodrĂ­guez GarcĂ­a Nº17, San Vicente del Raspeig, 03690, Alicante, Spain

    María-Dolores Tabar & Javier Tabar

  2. IDEXX Laboratories, Carrer del Plom 2, 08038, Barcelona, Spain

    Carolina Naranjo

  3. Vetgenomics, Parc de Recerca Universitat AutĂ²noma de Barcelona, Edifici Eureka, 08193, Bellaterra, Spain

    Laura Altet

  4. Hospital ClĂ­nic Veterinari, Universitat AutĂ²noma de Barcelona, Carrer de l´Hospital s/n, 08193, Bellaterra, Spain

    Xavier Roura

Authors
  1. MarĂ­a-Dolores Tabar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier Tabar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carolina Naranjo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura Altet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xavier Roura
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MDT and XR designed the study. MDT and JT were the clinicians who took the samples for the study and who were involved in the management of cases. LA performed the genetic tests and identified the final pathogen involved in the case report. CN performed the histological examination. MDT processed the database data and wrote the manuscript. XR was involved in drafting the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Xavier Roura.

Ethics declarations

Ethics approval and consent to participate

Collected data and samples used in this study were obtained from the diagnostic protocol and/or treatment of dogs included, under the verbal or written consent of the owners and in accordance with ethical guidelines of the International Council for Laboratory Animal Science.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests. XR is a member of the CVBD World Forum. The CVBD World Forum was founded during the 1st International CVBD Symposium from April 18th to 20th, 2006, in Billesley, UK, because of the increasing global threats through vector-borne diseases. The CVBD World Forum is supported by Elanco Animal Health.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Distribution of breeds among the study groups.

Additional file 2: Table S2.

Dogs with vector-borne pathogens detected (NA no abnormalities; LP lymphoplasmacytic; GR granulomatous; NIAD no infectious agent detected).

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tabar, MD., Tabar, J., Naranjo, C. et al. Detection of vector-borne pathogens in owned dogs with cranial cruciate ligament rupture living in the Mediterranean area. Parasites Vectors 15, 105 (2022). https://doi.org/10.1186/s13071-022-05205-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-022-05205-x

Keywords

Parasites & Vectors

ISSN: 1756-3305

Contact us